Do defecs in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?
- 1 April 1993
- journal article
- Published by Elsevier in Trends in Neurosciences
- Vol. 16 (4) , 125-131
- https://doi.org/10.1016/0166-2236(93)90117-5
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- MK‐801 Fails to Protect Against the Dopaminergic Neuropathology Produced by Systemic 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Mice or Intranigral 1‐Methyl‐4‐Phenylpyridinium in RatsJournal of Neurochemistry, 1992
- Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in alzheimer's brainsBiochemical and Biophysical Research Communications, 1992
- Leber's hereditary optic neuropathy and complex I deficiency in muscleAnnals of Neurology, 1991
- Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's diseaseBiochemical and Biophysical Research Communications, 1991
- Mitochondrial Complex I Deficiency in Parkinson's DiseaseJournal of Neurochemistry, 1990
- Movement disorders in mitochondrial myopathies. A study of nine cases with two autopsy studiesMovement Disorders, 1990
- Glutamate neurotoxicity and diseases of the nervous systemNeuron, 1988
- Therapy of mitochondrial disordersJournal of Inherited Metabolic Disease, 1987
- Regional Mitochondrial Respiratory Activity in Huntington's Disease BrainJournal of Neurochemistry, 1985
- Brain Lesions, Obesity, and Other Disturbances in Mice Treated with Monosodium GlutamateScience, 1969